Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (FRA:08HH)

Market Cap	7.06B -26.1%
Revenue (ttm)	5.49B +6.2%
Net Income	436.83M +4.4%
EPS	0.16 +5.2%
Shares Out	n/a
PE Ratio	16.15
Forward PE	18.17
Dividend	0.05 (2.61%)
Ex-Dividend Date	Jul 16, 2026

Volume	n/a
Open	1.926
Previous Close	1.881
Day's Range	1.926 - 1.926
52-Week Range	1.658 - 3.050
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About FRA:08HH

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, car...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 40,684
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 08HH

Financial Performance

In 2025, FRA:08HH's revenue was 41.66 billion, an increase of 1.45% compared to the previous year's 41.07 billion. Earnings were 3.37 billion, an increase of 21.69%.

Financial numbers in CNY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 19, 2026

Data Sources Report a data error